MEDXF - Medexus Pharmaceuticals reports Q1 results August, 08 2022 05:36 PM Medexus Pharmaceuticals Inc Medexus Pharmaceuticals press release ( OTCQX:MEDXF ): Q1 Revenue of C$23M (+32.9% Y/Y). Generated Adjusted Net Loss of C$3.6 million in fiscal Q1 2023, a C$6.2 million improvement compared to C$9.8 million in fiscal Q1 2022. For further details see: Medexus Pharmaceuticals reports Q1 results